Characterization of MEK1/2 Degraders Uncovers a Kinase-Independent Role for MEK1/2 in the Stabilization and Maturation of CRAF
Wasserman, J. S.; Kurimchak, A. M.; Herrera-Montavez, C.; Doyle, G. A.; Fox, B. D.; Kodikara, I. K. M.; Hu, X.; Hu, J.; Jin, J.; Duncan, J. S.
Show abstract
Altered MAPK signaling frequently occurs in human disease. MEK1 and MEK2 (MEK1/2) are central protein kinases in the MAPK signaling cascade that phosphorylate ERK1/2 promoting cell growth. MEK1/2 degraders offer a strategy to characterize both kinase-dependent and independent functions of MEK1/2. Here, we discovered that MEK1/2 degradation, but not kinase inhibition, caused the subsequent degradation of upstream kinase CRAF via a cell-intrinsic mechanism. MEK1/2 binding to CRAF, but not MEK1/2 catalytic activity, was required for CRAF protein stability and maturation to a functional kinase. In the absence of MEK1/2, a minor pool of newly synthesized immature CRAF that had anti-apoptotic functions remained. Finally, we showed that a stable primed CRAF-MEK1/2 signaling complex existed in cells that required RAS binding to potentiate MEK-ERK phosphorylation. Together, weve discovered a previously unrecognized kinase-independent function of MEK1/2, while contextualizing MEK1/2 as an integral component of the CRAF activation cycle beyond the conventional CRAF-MEK kinase- substrate paradigm.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Oncogenic PKA signaling stabilizes MYC oncoproteins via an aurora kinase A-dependent mechanism 96%
- A Cas-BCAR3 co-regulatory circuit controls lamellipodia dynamics 96%
- The integrated stress response remodels the microtubule organizing center to clear unfolded proteins following proteotoxic stress 95%
Similar papers in this journal
- PPP6C negatively regulates oncogenic ERK signaling through dephosphorylation of MEK 95%
- The selective autophagy receptor p62 and the heat shock protein HSP27 facilitate lysophagy via the formation of phase-separated condensates 95%
- A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation 95%
Similar papers in this journal
- Proteasome Regulation by Reversible Tyrosine Phosphorylation at the Membrane 94%
- ISGylation drives basal breast tumour progression by promoting EGFR recycling and Akt signalling 94%
- Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers 94%
Similar papers in this journal
- MICU1 regulates mitochondrial cristae structure and function independent of the mitochondrial calcium uniporter channel 94%
- RASSF effectors couple diverse RAS subfamily GTPases to the Hippo pathway 94%
- Reporter-based screening identifies RAS-RAF stabilizing mutations as drivers of resistance to broad-spectrum RAS inhibition in colorectal cancer 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.